Article Versions Notes

Sacco R, Ramai D, Tortora R, di Costanzo GG, Burlone ME, Pirisi M, Federico P, Daniele B, Silletta M, Gallo P, et al. Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis. Cancers. 2023; 15(2):381. https://doi.org/10.3390/cancers15020381

Sacco, Rodolfo, Daryl Ramai, Raffaella Tortora, Giovan Giuseppe di Costanzo, Michela Emma Burlone, Mario Pirisi, Piera Federico, Bruno Daniele, Marianna Silletta, Paolo Gallo, and et al. 2023. "Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis" Cancers 15, no. 2: 381. https://doi.org/10.3390/cancers15020381

Sacco, R., Ramai, D., Tortora, R., di Costanzo, G. G., Burlone, M. E., Pirisi, M., Federico, P., Daniele, B., Silletta, M., Gallo, P., Cocuzza, C., Russello, M., Cabibbo, G., Rancatore, G., Cesario, S., Masi, G., Marzi, L., Mega, A., Granito, A., ... Facciorusso, A., on behalf of A.I.G.O. (Italian Association of Hospital Gastroenterologists). (2023). Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis. Cancers, 15(2), 381. https://doi.org/10.3390/cancers15020381